Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides

Equality Impact Assessment (Guidance development) (PDF 169 KB)

Register of interests (PDF 270 KB)

Final draft guidance

Final appraisal document (PDF 278 KB)

Committee papers (PDF 1.31 MB)

Public committee slides (PDF 932 KB)

Draft guidance: 2

Appraisal consultation document (PDF version) (PDF 318 KB)

Appraisal consultation document (online commenting)

Committee papers (PDF 2.01 MB)

Public committee slides (PDF 1.24 MB)

Draft guidance

Appraisal consultation document (PDF version) (PDF 308 KB)

Appraisal consultation document (online commenting)

Committee papers (PDF 4.09 MB)

Public committee slides (PDF 1.4 MB)

Final stakeholder list (PDF 160 KB)

Final scope (PDF 175 KB)

Equality impact assessment (Scoping) (PDF 126 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 871 KB)

Draft scope post referral (PDF 212 KB)

Draft matrix post referral (PDF 170 KB)